Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mwangi

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Blood Cancer Journal|July 3, 2025
Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detectionSuheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, et al.
Blood Advances|January 8, 2025
The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online toolMatthew J Maurer, Susan K Parsons, Jenica N Upshaw, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2021
Vaccination History and Risk of Lymphoma and Its Major SubtypesGeffen Kleinstern, Melissa C Larson, Stephen M Ansell, et al.
Hemasphere|September 13, 2021
Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic CriteriaRebecca L King, Arushi Khurana, Raphael Mwangi, et al.
Blood Advances|July 11, 2024
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCLArushi Khurana, Raphael Mwangi, Loretta J Nastoupil, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2026
No association of prior administration of selected vaccines with lymphoma prognosisGeorge A Cholack, Verena Hinder, Raphael Mwangi, et al.
Bone Marrow Transplantation|February 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosisEli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
British Journal of Haematology|March 10, 2026
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypesGeorge A Cholack, Raphael Mwangi, Prokop Vodička, et al.
Blood Cancer Journal|May 3, 2022
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohortsSanjal H Desai, Levi Pederson, Betsy LaPlant, et al.
Blood Advances|July 18, 2022
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort studyAung M Tun, Arushi Khurana, Raphael Mwangi, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Blood Cancer Journal|July 3, 2025
Incidental vs. symptomatic diagnosis of follicular lymphoma: implications of earlier detectionSuheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, et al.
Blood Advances|January 8, 2025
The A-HIPI prediction model in advanced-stage Hodgkin lymphoma: identification of risk groups and creation of an online toolMatthew J Maurer, Susan K Parsons, Jenica N Upshaw, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2021
Vaccination History and Risk of Lymphoma and Its Major SubtypesGeffen Kleinstern, Melissa C Larson, Stephen M Ansell, et al.
Hemasphere|September 13, 2021
Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic CriteriaRebecca L King, Arushi Khurana, Raphael Mwangi, et al.
Blood Advances|July 11, 2024
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCLArushi Khurana, Raphael Mwangi, Loretta J Nastoupil, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2026
No association of prior administration of selected vaccines with lymphoma prognosisGeorge A Cholack, Verena Hinder, Raphael Mwangi, et al.
Bone Marrow Transplantation|February 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosisEli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
British Journal of Haematology|March 10, 2026
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypesGeorge A Cholack, Raphael Mwangi, Prokop Vodička, et al.
Blood Cancer Journal|May 3, 2022
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohortsSanjal H Desai, Levi Pederson, Betsy LaPlant, et al.
Blood Advances|July 18, 2022
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort studyAung M Tun, Arushi Khurana, Raphael Mwangi, et al.
Pageof 5